» Articles » PMID: 21274866

Relationship Between the Pattern of Hepatic Iron Deposition and Histological Severity in Nonalcoholic Fatty Liver Disease

Overview
Journal Hepatology
Specialty Gastroenterology
Date 2011 Jan 29
PMID 21274866
Citations 144
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Previous studies examining the relationship between hepatic iron deposition and histological severity in nonalcoholic fatty liver disease (NAFLD) have been inconclusive. The goal of this study was to examine the relationship between hepatic iron deposition and liver histology in 849 patients enrolled in the Nonalcoholic Steatohepatitis Clinical Research Network. Hepatic iron staining was performed in a central laboratory, and the stains were scored for grade and cellular and parenchymal localization by a central pathology committee; the relationship between the grade and pattern of iron deposition and the clinical, laboratory, and histological variables was examined with univariate and multivariate analyses. Stainable hepatic iron was present in 293 of 849 patients (34.5%) in one of three histological patterns: a hepatocellular (HC) pattern [63/849 (7.4%)], a reticuloendothelial system (RES) cell pattern [91/849 (10.7%)], or a mixed RES/HC pattern [139/849 (16.4%)]. Patients with the RES iron-staining pattern were more likely to have advanced fibrosis compared to those with those with HC iron (P = 0.01). Patients with RES iron were also more likely to have advanced histological features such as fibrosis (P = 0.049), portal inflammation (P = 0.002), HC ballooning (P = 0.006), and definite nonalcoholic steatohepatitis (P = 0.007) compared to those with patients with HC or mixed iron patterns. The presence of RES iron (odds ratio = 1.60, 95% confidence interval = 1.10-2.33, P = 0.015) was independently associated with advanced hepatic fibrosis on multiple regression analysis after adjustments for age, gender, diabetes status, and body mass index.

Conclusion: The presence and pattern of hepatic iron deposition are associated with distinct histological features in patients with NAFLD and may have implications for pathophysiology and therapy.

Citing Articles

From mechanisms to medicine: Ferroptosis as a Therapeutic target in liver disorders.

He Y, Lin Y, Song J, Song M, Nie X, Sun H Cell Commun Signal. 2025; 23(1):125.

PMID: 40055721 PMC: 11889974. DOI: 10.1186/s12964-025-02121-2.


-derived acetate activates the hepatic AMPK/SIRT1/PGC-1 axis to alleviate ferroptosis in metabolic-associated fatty liver disease.

Zhuge A, Li S, Han S, Yuan Y, Shen J, Wu W Acta Pharm Sin B. 2025; 15(1):151-167.

PMID: 40041901 PMC: 11873632. DOI: 10.1016/j.apsb.2024.10.010.


Iron metabolism in non-alcoholic fatty liver disease: A promising therapeutic target.

Chen H Liver Res. 2025; 6(4):203-213.

PMID: 39957910 PMC: 11791839. DOI: 10.1016/j.livres.2022.09.003.


Iron overload is closely associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes.

Qu H, Zhou L, Wang J, Tang D, Zhang Q, Shi J Obesity (Silver Spring). 2025; 33(3):490-499.

PMID: 39915040 PMC: 11897857. DOI: 10.1002/oby.24236.


Digging the metabolic roots of NASH up.

Baldelli E, Lonardo A Life Metab. 2025; 1(3):203-204.

PMID: 39872078 PMC: 11749814. DOI: 10.1093/lifemeta/loac036.


References
1.
Videla L, Fernandez V, Tapia G, Varela P . Oxidative stress-mediated hepatotoxicity of iron and copper: role of Kupffer cells. Biometals. 2003; 16(1):103-11. DOI: 10.1023/a:1020707811707. View

2.
Xiong S, She H, Takeuchi H, Han B, Engelhardt J, Barton C . Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem. 2003; 278(20):17646-54. DOI: 10.1074/jbc.M210905200. View

3.
Wrighting D, Andrews N . Interleukin-6 induces hepcidin expression through STAT3. Blood. 2006; 108(9):3204-9. PMC: 1895528. DOI: 10.1182/blood-2006-06-027631. View

4.
Price L, Kowdley K . The role of iron in the pathophysiology and treatment of chronic hepatitis C. Can J Gastroenterol. 2009; 23(12):822-8. PMC: 2805519. DOI: 10.1155/2009/290383. View

5.
Lin M, Rippe R, Niemela O, Brittenham G, Tsukamoto H . Role of iron in NF-kappa B activation and cytokine gene expression by rat hepatic macrophages. Am J Physiol. 1997; 272(6 Pt 1):G1355-64. DOI: 10.1152/ajpgi.1997.272.6.G1355. View